Learn More
Medchemexpress LLC IRAK4-IN-7 | 1801343-74-7 | 99.36% | 417.42 | 500 UG

Supplier: Medchemexpress LLC HY10958550MG
IRAK4-IN-7 is a selective, potent, and orally active interleukin-1 receptor-associated kinase 4 (IRAK4) inhibitor, extracted from patent WO2015104688 (example 1). It has potential for cancer and inflammatory disease treatment. It exhibits anti-cancer and anti-inflammatory activities.
- Selective and potent IRAK4 inhibitor
- Orally active
- Potential for cancer treatment
- Potential for inflammatory disease treatment
- Exhibits anti-cancer activities
- Exhibits anti-inflammatory activities
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.